Page 1 of Clinical Trials for Primary Hypercholesterolemia, 696 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Trial to Assess the Effects of P-OM3 on LDL-C in Subjects With Primary Hypercholesterolemia
Last Updated: January 26, 2010
Condition(s): Primary Hypercholesterolemia
2
Completed
Study of Oral MD-0727 Administered to Patients With Primary Hypercholesterolemia
Last Updated: September 28, 2007
Condition(s): Hypercholesterolemia
3
Completed
Phase 2 Dose-Ranging Efficacy and Safety Trial of SCH 900271 in Subjects With Primary Hypercholesterolemia or Mixed Hyperlipidemia (P05675)(COMPLETED)
Last Updated: April 13, 2010
Condition(s): Primary Hypercholesterolemia; Mixed Hyperlipidemia
4
Completed
Pediatric Study to Evaluate the Efficacy and Safety of Ezetimibe Monotherapy in Children With Primary Hypercholesterolemia (Study P05522)
Last Updated: April 26, 2012
Condition(s): Primary Hypercholesterolemia
5
Terminated
Evaluation of Efficacy and Safety of AVE5530 in Patients With Primary Hypercholesterolemia
Last Updated: September 22, 2009
Condition(s): Hypercholesterolemia
6
Terminated
Evaluation of Efficacy and Safety of AVE5530 Co-administered With Atorvastatin in Primary Hypercholesterolemia
Last Updated: November 10, 2009
Condition(s): Hypercholesterolemia
7
Completed
A Study to Evaluate the Effects of MK0653 on the Postprandial (Following a Meal) Lipoprotein Response in Patients With Primary Hypercholesterolemia (High Cholesterol)
Last Updated: January 25, 2010
Condition(s): Hypercholesterolemia
8
Completed
Eprotirome for the Treatment of Dyslipidemia, Efficacy and Safety 12-Week, Phase ii Study to Assess the Safety and Efficacy of KB2115 in Patients With Primary Hypercholesterolemia
Last Updated: October 20, 2008
Condition(s): Primary Hypercholesterolemia
9
Terminated
A Study to Evaluate Efficacy and Safety of Extended-Release Niacin (+) Laropiprant (+) Simvastatin in Participants With Primary Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-118)
Last Updated: April 12, 2012
Condition(s): Primary Hypercholesterolemia; Dyslipidemia
10
Completed
Study on the Safety and Effects on Lipids of FM-VP4 in Subjects With Primary Hypercholesterolemia
Last Updated: February 22, 2007
Condition(s): Hypercholesterolemia
11
Completed
Study of Extended Release Niacin/Laropiprant on Lipids (0524A-067)(COMPLETED)
Last Updated: March 9, 2012
Condition(s): Primary Hypercholesterolemia; Mixed Dyslipidemia
12
Completed
Lipid Efficacy Study
Last Updated: March 6, 2008
Condition(s): Primary Hypercholesterolemia; Mixed Hyperlipidemia
13
Completed
MK0524B Lipid Study
Last Updated: July 30, 2008
Condition(s): Primary Hypercholesterolemia; Mixed Dyslipidemia
14
Completed
A Study to Evaluate the Effects of Laropiprant on the Antiplatelet Effects of Clopidogrel and Aspirin in Combination (MK-0524A-114)(COMPLETED)
Last Updated: March 24, 2011
Condition(s): Primary Hypercholesterolemia; Hyperlipidemia, Familial Combined
15
Terminated
Evaluation of Safety and Efficacy of AVE5530 as add-on to Ongoing Statins in Patients With Primary Hypercholesterolemia
Last Updated: November 10, 2009
Condition(s): Hypercholesterolemia
16
Completed
Comparison of Ezetimibe Plus Simvastatin Versus Ezetimibe or Simvastatin Alone in Subjects With Primary Hypercholesterolemia (Study P03757)(COMPLETED)
Last Updated: March 31, 2008
Condition(s): Hypercholesterolemia
17
Completed
Effects of Vytorin Versus Placebo in Subjects With Primary Hypercholesterolemia (Study P04420)(COMPLETED)
Last Updated: June 3, 2010
Condition(s): Hypercholesterolemia
18
Completed
Ezetimibe Plus Simvastatin Versus Simvastatin Alone in African-American Subjects With Primary Hypercholesterolemia (P03377)
Last Updated: March 31, 2008
Condition(s): Hypercholesterolemia; Atherosclerosis
19
Recruiting
Efficacy and Safety of Extended Release (ER) Niacin/Laropiprant When Added to Ongoing Lipid-Modifying Therapy in Patients With High Cholesterol or Abnormal Lipid Levels (Protocol MK-0524A-133 AM1)
Last Updated: April 26, 2012
Condition(s): Primary Hypercholesterolemia; Mixed Dyslipidemia
20
Not yet recruiting
Efficacy and Safety of FDC in High Risk Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
Last Updated: August 18, 2011
Condition(s): Hypercholesterolemia; Dyslipidemia

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Primary+Hypercholesterolemia

Page 1 of Clinical Trials for Primary Hypercholesterolemia, 696 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About